AxoGen, Inc. – LSE:0HKD.L
AxoGen stock price today
AxoGen stock price monthly change
AxoGen stock price quarterly change
AxoGen stock price yearly change
AxoGen key metrics
Market Cap | 706.33M |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | -0.49 |
Revenue | 163.72M |
EBITDA | -12.75M |
Income | -21.27M |
Revenue Q/Q | 12.85% |
Revenue Y/Y | 13.50% |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | -7.79% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeAxoGen stock price history
AxoGen stock forecast
AxoGen financial statements
| Jun 2023 | 38.15M | -6.66M | -17.46% |
|---|---|---|---|
| Sep 2023 | 41.27M | -4.08M | -9.91% |
| Dec 2023 | 42.92M | -3.89M | -9.07% |
| Mar 2024 | 41.37M | -6.63M | -16.04% |
| Sep 2025 | 51.90M | 2.37M | 4.58% |
|---|---|---|---|
| Oct 2025 | 52.15M | 3.60M | 6.92% |
| Dec 2025 | 53.8M | 4.26M | 7.92% |
| Mar 2026 | 52.86M | 3.95M | 7.48% |
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 191641000 | 94.48M | 49.31% |
|---|---|---|---|
| Sep 2023 | 194630000 | 96.82M | 49.75% |
| Dec 2023 | 196827000 | 101.16M | 51.4% |
| Mar 2024 | 186516000 | 93.36M | 50.05% |
| Jun 2023 | 292K | 14.32M | 898K |
|---|---|---|---|
| Sep 2023 | 1.62M | 5.99M | 5K |
| Dec 2023 | -211K | -277K | 418K |
| Mar 2024 | -12.26M | -3.25M | 204K |
AxoGen alternative data
| Aug 2023 | 394 |
|---|---|
| Sep 2023 | 394 |
| Oct 2023 | 394 |
| Nov 2023 | 394 |
| Dec 2023 | 394 |
| Jan 2024 | 394 |
| Feb 2024 | 394 |
| Mar 2024 | 426 |
| Apr 2024 | 426 |
| May 2024 | 426 |
| Jun 2024 | 426 |
| Jul 2024 | 426 |
AxoGen other data
| Insider | Compensation |
|---|---|
| Ms. Karen Zaderej (1962) Chairman, Pres & Chief Executive Officer | $999,960 |
Mr. Angelo G. Scopelianos Ph.D. (1955) Vice President of R&D | $554,140 |
| Mr. Peter J. Mariani (1964) Chief Financial Officer | $548,030 |
| Mr. Eric A. Sandberg (1965) Chief Commercial Officer | $476,800 |
| Ms. Maria D. Martinez (1968) Chief HR Officer | $460,480 |
| Mr. Gregory Davault Vice President of Marketing | |
Mr. Brad Ottinger Gen. Counsel & Chief Compliance Officer | |
Mr. Michael Donovan Vice President of Operations | |
| Ms. Isabelle Billet Chief Strategy & Bus. Devel. Officer | |
Mr. David Hansen Vice President of Fin. & Treasurer |
-
What's the price of AxoGen stock today?
One share of AxoGen stock can currently be purchased for approximately $43.9.
-
When is AxoGen's next earnings date?
Unfortunately, AxoGen's (0HKD.L) next earnings date is currently unknown.
-
Does AxoGen pay dividends?
No, AxoGen does not pay dividends.
-
How much money does AxoGen make?
AxoGen has a market capitalization of 706.33M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 14.74% to 159.01M US dollars.
-
What is AxoGen's stock symbol?
AxoGen, Inc. is traded on the LSE under the ticker symbol "0HKD.L".
-
What is AxoGen's primary industry?
Company operates in the Healthcare sector and Medical - Equipment & Services industry.
-
How do i buy shares of AxoGen?
Shares of AxoGen can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are AxoGen's key executives?
AxoGen's management team includes the following people:
- Ms. Karen Zaderej Chairman, Pres & Chief Executive Officer(age: 63, pay: $999,960)
- Mr. Angelo G. Scopelianos Ph.D. Vice President of R&D(age: 70, pay: $554,140)
- Mr. Peter J. Mariani Chief Financial Officer(age: 61, pay: $548,030)
- Mr. Eric A. Sandberg Chief Commercial Officer(age: 60, pay: $476,800)
- Ms. Maria D. Martinez Chief HR Officer(age: 57, pay: $460,480)
- Mr. Gregory Davault Vice President of Marketing
- Mr. Brad Ottinger Gen. Counsel & Chief Compliance Officer
- Mr. Michael Donovan Vice President of Operations
- Ms. Isabelle Billet Chief Strategy & Bus. Devel. Officer
- Mr. David Hansen Vice President of Fin. & Treasurer
-
How many employees does AxoGen have?
As Jul 2024, AxoGen employs 426 workers.
-
When AxoGen went public?
AxoGen, Inc. is publicly traded company for more then 7 years since IPO on 29 Jan 2018.
-
What is AxoGen's official website?
The official website for AxoGen is axogeninc.com.
-
Where are AxoGen's headquarters?
AxoGen is headquartered at 13631 Progress Boulevard, Alachua, FL.
-
How can i contact AxoGen?
AxoGen's mailing address is 13631 Progress Boulevard, Alachua, FL and company can be reached via phone at +386 4626800.
AxoGen company profile:
AxoGen, Inc.
axogeninc.comLSE
426
Medical - Equipment & Services
Healthcare
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and Avive Soft Tissue Membrane, a processed human umbilical cord membrane that can be used as a resorbable soft tissue covering to separate tissues in the surgical bed. In addition, the company offers AxoTouch two point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. It provides its products to hospitals, surgery centers, and military hospitals plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons in the United States, Canada, Germany, the United Kingdom and other European countries, South Korea, and internationally. AxoGen, Inc. is headquartered in Alachua, Florida.
Alachua, FL 32615
:
ISIN: US05463X1063
:
